Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7002 results

Sort By:

Specimen Banking From Patients With Lung Cancer

Study ID: NCT01585675
Start Date: 2005-11-03
End Date: 2035-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment
Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

Study ID: NCT06229912
Start Date: 2024-06-04
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Revumenib

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Study ID: NCT06149481
Start Date: 2024-03-26
End Date: 2030-10-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Retifanlimab

Therapeutic CEA, Brachyury and MUC1 TriAdeno Vaccine Platform

N-803

SX-682

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Hypofractionated Radiation Therapy for Merkel Cell Carcinoma

Study ID: NCT05100095
Start Date: 2021-12-14
End Date: 2028-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

52

Intervention / Treatment

Radiation therapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

STARLITE for Unresectable High-Grade Gliomas

Study ID: NCT06428045
Start Date: 2025-04-15
End Date: 2030-04-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Magnetic Resonance (MR)-guided Laser Interstitial Thermal Therapy (LITT)

Abasavir

Lamivudine

Ritonavir

Temozolomide

Focal Radiotherapy

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Hairy Cell Leukemia Patient Data Registry

Study ID: NCT02560883
Start Date: 2013-01-02
End Date: 2030-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5000

Intervention / Treatment
Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Study ID: NCT06661720
Start Date: 2025-03-14
End Date: 2037-11
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1040

Intervention / Treatment

Pembrolizumab

Quietly

Biospecimen Collection

MRI

Computed Tomography

Biopsy

Administration Questionnaire

Sponsor

Alliance for Clinical Trials in Oncology

Source: clinicaltrials.gov

Share:
Add to list

Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study

Study ID: NCT05257551
Start Date: 2022-07-13
End Date: 2026-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Observation

Sponsor

Tempus AI

Source: clinicaltrials.gov

Share:
Add to list

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

Study ID: NCT04406831
Start Date: 2015-04
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Blood draw

Sponsor

Nuvance Health

Source: clinicaltrials.gov

Share:
Add to list

Prescription of Letrozole for Uterine Myoma

Study ID: NCT06143631
Start Date: 2024-07-24
End Date: 2027-04-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

140

Intervention / Treatment

Letrozole 2.5mg

Placebo

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list